What the FDA says, in its own words
Compounded GLP-1s are not FDA-approved
Unapproved versions skip FDA's review for safety, effectiveness and quality.
“FDA is aware that some patients and health care professionals may look to unapproved versions of GLP-1”
Dosing errors put people in hospital
Patients and clinicians miscalculated compounded doses; some took more than the label allows.
“FDA received multiple reports of adverse events, some requiring hospitalization, that may be related to dosing errors associated with compounded injectable semaglutide products. These dosing errors resulted from patients measuring and self-administering incorrect doses of the drug, and in some cases, health care professionals miscalculating doses of the drug. Additionally, the agency has received adverse event reports that may be related to patients prescribed compounded semaglutide or tirzepatide products in doses beyond what is in the FDA-approved drug label.”
Fake labels, warm boxes, old vials
Labels naming pharmacies that do not exist, shipments that arrive warm, vials used past 28 days.
“FDA is aware of fraudulent compounded semaglutide and tirzepatide marketed in the U.S. that contain false information on the product label. In some cases, the compounding pharmacies identified on the labels of the products do not exist. In other cases, the labels”
Who inspects the pharmacy
503B outsourcing facilities are FDA-inspected; 503A pharmacies are overseen by state boards.
“Compounded drugs are not FDA-approved. This means that FDA does not verify the safety, effectiveness or quality of compounded drugs before they are marketed.”
The full FDA list, item by item: is compounded semaglutide safe?
Six checks before you pay anyone
Refrigerated on arrival
Warm box: do not use it
FDA recommends not using any injectable GLP-1 that arrives warm or with too little ice.
A real, named pharmacy
Check the license
FDA has seen labels naming pharmacies that do not exist. Look the pharmacy up with your state board of pharmacy.
Units, not guesses
Measure the dose right
Dosing errors are the most reported harm. Convert mg to syringe units from your own vial's label.
Dose converter →28 days, then discard
Even if some is left
FDA: discard a multi-dose vial 28 days after first use, whatever the compounder's label says.
A prescription first
No exam, no sale
Compounded drugs are for patients a clinician has assessed. A seller that skips that step is a red flag.
Who oversees it
503A or 503B?
Ask which: 503B outsourcing facilities are inspected by FDA and held to manufacturing standards; 503A pharmacies are not.
Every program we track, checked
Each program has a nine-point legitimacy page: prescribing model, pharmacy, certification, reviews, cancellation and more, computed from what we could and could not verify.
LegitScript: 3 of 26 show a certification we could verify.
- Is Wellmedr legit?
- Is Embody legit?
- Is SnagRx legit?
- Is Gala Health legit?
- Is Collective legit?
- Is CoreAge Rx legit?
- Is Idun Rx legit?
- Is Arbor legit?
- Is bmiMD legit?
- Is Sprout Health legit?
- Is HealthRX legit?
- Is Strut Health legit?
- Is Mochi Health legit?
- Is PeterMD legit?
- Is Bodybuilding.com Health+ legit?
- Is Found legit?
- Is EverPrime (Enhance MD) legit?
- Is ShedRx legit?
- Is DudeMeds legit?
- Is SkinnyRx legit?
- Is RxSpan MD legit?
- Is Sesame Care legit?
- Is Lemonaid Health legit?
- Is Direct Meds GLP-1 legit?
- Is Wellorithm legit?
- Is Oak Longevity legit?
FDA records, one page each
- 164 FDA warning letters naming GLP-1 drugs
Recipient, date, drugs named, closeout status and FDA’s own words for every letter.
- 100 FDA-registered 503B outsourcing facilities
Registration, last inspection, Form 483 and recall, as FDA’s register lists them.
- 108 firms on GLP-1 labels
Every firm in FDA’s drug listings for a GLP-1, with its products, approvals, recalls and letters on one page.
- 100 FDA recalls of GLP-1 drugs
Firm, class, status and FDA’s stated reason for every recall naming a GLP-1.
- FDA’s GLP-1 shortage list today
What FDA's shortage database lists for each molecule, updated by FDA Nov 17, 2026.
- These records, counted
How many 503B facilities FDA marks “Not yet inspected”, how many letters it sent this year, and what Medicaid and Medicare spend on GLP-1s.
Check it yourself
- FDA BeSafeRx ↗
How to tell a legitimate online pharmacy from a fake one.
- FDA register of 503B outsourcing facilities ↗
Every facility registered with FDA, with inspection details.
- FDA MedWatch ↗
Report a side effect or a bad product to FDA.
- LegitScript ↗
Look up whether a telehealth site is certified.
- NABP (state boards of pharmacy) ↗
Find your state board to check a pharmacy's license.



